COGT Competitors & Alternatives
Compare Cogent Biosciences Inc with similar stocks in the same industry
Biotechnology
COGT
Main Stock$31.53
Tradestie Score
48
Market Cap
$1.97B
Revenue Growth
-1.0%
Analyst Upside
+72.1%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CYTK
Cytokinetics Inc.
|
$75.76
|
$6.68B | - | 61 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$86.44
|
$6.64B | - | 56 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$111.33
|
$6.38B | - | 48 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$27.41
|
$6.03B | - | 57 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$48.33
|
$6.02B | - | 56 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$99.07
|
$5.95B | - | 56 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$226.64
|
$5.92B | - | 61 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$39.68
|
$5.80B | 14.9 | 56 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$291.62
|
$5.20B | 41.3 | 65 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$49.07
|
$4.94B | - | 56 | Compare |
More COGT Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry